DZ2515A1 - Dérivés de macrolides substitués en position c-4. - Google Patents

Dérivés de macrolides substitués en position c-4.

Info

Publication number
DZ2515A1
DZ2515A1 DZ980125A DZ980125A DZ2515A1 DZ 2515 A1 DZ2515 A1 DZ 2515A1 DZ 980125 A DZ980125 A DZ 980125A DZ 980125 A DZ980125 A DZ 980125A DZ 2515 A1 DZ2515 A1 DZ 2515A1
Authority
DZ
Algeria
Prior art keywords
derivatives substituted
macrolide derivatives
macrolide
substituted
derivatives
Prior art date
Application number
DZ980125A
Other languages
English (en)
Inventor
Brian Scott Bronk
Takushi Kaneko
Michael Anthony Letavic
Hengmiao Cheng
Edward Alan Glazer
Beingwei Vera Yang
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ2515A1 publication Critical patent/DZ2515A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DZ980125A 1997-06-11 1998-06-10 Dérivés de macrolides substitués en position c-4. DZ2515A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4998097P 1997-06-11 1997-06-11

Publications (1)

Publication Number Publication Date
DZ2515A1 true DZ2515A1 (fr) 2003-02-01

Family

ID=21962765

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980125A DZ2515A1 (fr) 1997-06-11 1998-06-10 Dérivés de macrolides substitués en position c-4.

Country Status (40)

Country Link
EP (1) EP0988309B1 (fr)
JP (1) JP3262806B2 (fr)
KR (1) KR100369959B1 (fr)
CN (1) CN1145636C (fr)
AP (1) AP1189A (fr)
AR (1) AR013085A1 (fr)
AT (1) ATE310742T1 (fr)
AU (1) AU745006C (fr)
BG (1) BG64357B1 (fr)
BR (1) BR9810097A (fr)
CA (1) CA2293397C (fr)
CO (1) CO4950584A1 (fr)
DE (1) DE69832486T2 (fr)
DZ (1) DZ2515A1 (fr)
EA (1) EA002440B1 (fr)
ES (1) ES2251081T3 (fr)
GT (1) GT199800075A (fr)
HK (1) HK1025974A1 (fr)
HN (1) HN1998000074A (fr)
HR (1) HRP980315A2 (fr)
HU (1) HUP0004076A3 (fr)
ID (1) ID24530A (fr)
IL (1) IL132808A (fr)
IS (1) IS1979B (fr)
MA (1) MA24563A1 (fr)
MY (1) MY133027A (fr)
NO (1) NO315560B1 (fr)
NZ (1) NZ500652A (fr)
OA (1) OA11226A (fr)
PA (1) PA8452001A1 (fr)
PE (1) PE79999A1 (fr)
PL (1) PL337497A1 (fr)
SK (1) SK168299A3 (fr)
TN (1) TNSN98084A1 (fr)
TW (2) TWI224106B (fr)
UA (1) UA70298A (fr)
UY (1) UY25041A1 (fr)
WO (1) WO1998056801A1 (fr)
YU (1) YU62999A (fr)
ZA (1) ZA985016B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1011689T3 (da) * 1997-09-10 2007-05-21 Merial Ltd Anvendelse af 9a-azalider som veterinære antimikrobielle midler
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
EP1779853A3 (fr) * 1997-09-10 2010-01-27 Merial Ltd. 9a-azalides en tant qu'agents anti-microbiens à usage vétérinaire
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (fr) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11-carbamates des macrolides antibactériens
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
KR20010083944A (ko) 1998-11-03 2001-09-03 실버스타인 아써 에이. 신규 마크롤라이드 항생물질
CA2292359C (fr) * 1999-01-28 2004-09-28 Pfizer Products Inc. Nouveaux azalides et procede de fabrication
ES2256030T3 (es) * 1999-08-24 2006-07-16 Abbott Laboratories 9a-azalidas con actividad antibacteriana.
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
NZ518665A (en) * 2000-01-27 2005-02-25 Pfizer Prod Inc Azalide antibiotic compositions
EP1383780A1 (fr) * 2001-04-27 2004-01-28 Pfizer Products Inc. Procede de preparation de derives de 9-deoxo-9a-aza-9a-homoerythromycine a substitues en 4''
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
ATE429441T1 (de) 2002-07-08 2009-05-15 Glaxosmithkline Zagreb Hybridmoleküle von makroliden mit steroidalen/nicht-steroidalen antientzündlich aktiven molekülen
AU2003255849A1 (en) * 2002-07-08 2004-01-23 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use
AU2003255851B2 (en) 2002-07-08 2009-07-23 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. New compounds, compositions and methods for treatment of inflammatory diseases and conditions
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
EP2772254A3 (fr) * 2003-03-10 2015-03-11 Optimer Pharmaceuticals, Inc. Nouveaux agents antibactériens
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
CN102816194A (zh) 2004-02-27 2012-12-12 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法
EP2177526A4 (fr) 2007-08-06 2012-08-22 Taisho Pharmaceutical Co Ltd Composé 10a-azalide réticulé en position 10a et en position 12
JP5698979B2 (ja) 2007-10-25 2015-04-08 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド系抗菌剤の調製プロセス
JPWO2009139181A1 (ja) 2008-05-15 2011-09-15 大正製薬株式会社 ４員環構造を有する１０ａ−アザライド化合物
CN105616437A (zh) 2008-10-24 2016-06-01 森普拉制药公司 使用含三唑的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US8940880B2 (en) * 2010-09-20 2015-01-27 Novartis Ag Process for the preparation of 9-deoxo-9a-homoerythromycin A, modified in the C-4″ of the cladinose ring by an epoxide group
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
RU2658050C2 (ru) 2012-03-27 2018-06-19 Семпра Фармасьютикалз, Инк. Парентеральные составы для введения макролидных антибиотиков
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 Ｃ−４”位置換マクロライド誘導体を含有する医薬
EP2988597B1 (fr) 2013-04-04 2022-06-08 President and Fellows of Harvard College Macrolides et leurs procédés de préparation et d'utilisation
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
AR102810A1 (es) 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
JP2017531663A (ja) 2014-10-08 2017-10-26 プレジデント アンド フェローズ オブ ハーバード カレッジ １４員ケトライドならびにそれらの調製および使用の方法
EP3273969A4 (fr) 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides à sucres modifiés de type désosamine et utilisations de ceux-ci
CN108003207B (zh) 2017-12-19 2019-05-10 海门慧聚药业有限公司 制备泰拉霉素的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
SE445223B (sv) * 1977-02-04 1986-06-09 Pfizer Sett att framstella 4"-amino-erytomylin-a-derivat
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
DE3475073D1 (en) * 1983-09-06 1988-12-15 Pfizer Azahomoerythromycin b derivatives and intermediates thereof
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
CA2064634C (fr) * 1991-04-04 1998-08-04 James V. Heck Derives de 9-desoxo-8a-aza-8a-homoerythromycine a modifies en positions 4"- et 8a
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5412982A (en) * 1994-03-10 1995-05-09 Potts; James K. Windsock support

Also Published As

Publication number Publication date
KR20010013633A (ko) 2001-02-26
ES2251081T3 (es) 2006-04-16
DE69832486D1 (de) 2005-12-29
CN1259955A (zh) 2000-07-12
UA70298C2 (uk) 2004-10-15
YU62999A (sh) 2002-10-18
BG103969A (en) 2000-07-31
JP2000514097A (ja) 2000-10-24
UA70298A (uk) 2004-10-15
MY133027A (en) 2007-10-31
PA8452001A1 (es) 2000-05-24
CN1145636C (zh) 2004-04-14
EP0988309A1 (fr) 2000-03-29
TW200418871A (en) 2004-10-01
PL337497A1 (en) 2000-08-28
JP3262806B2 (ja) 2002-03-04
UY25041A1 (es) 2000-09-29
CA2293397C (fr) 2004-08-31
AP9801254A0 (en) 1998-06-30
IS5250A (is) 1999-11-16
EP0988309B1 (fr) 2005-11-23
GT199800075A (es) 1999-11-30
AU745006B2 (en) 2002-03-07
HRP980315A2 (en) 1999-04-30
NO315560B1 (no) 2003-09-22
CA2293397A1 (fr) 1998-12-17
AP1189A (en) 2003-07-16
HN1998000074A (es) 1999-01-08
CO4950584A1 (es) 2000-09-01
IL132808A (en) 2004-08-31
BR9810097A (pt) 2000-08-08
IL132808A0 (en) 2001-03-19
NZ500652A (en) 2001-10-26
EA002440B1 (ru) 2002-04-25
AU7228198A (en) 1998-12-30
HUP0004076A3 (en) 2003-05-28
NO996107D0 (no) 1999-12-10
AR013085A1 (es) 2000-12-13
ZA985016B (en) 1999-12-10
IS1979B (is) 2005-01-14
PE79999A1 (es) 1999-08-25
NO996107L (no) 2000-02-10
HK1025974A1 (en) 2000-12-01
KR100369959B1 (ko) 2003-02-12
MA24563A1 (fr) 1998-12-31
TNSN98084A1 (fr) 2005-03-15
OA11226A (en) 2003-07-16
WO1998056801A1 (fr) 1998-12-17
ATE310742T1 (de) 2005-12-15
ID24530A (id) 2000-07-20
BG64357B1 (bg) 2004-11-30
HUP0004076A2 (hu) 2001-04-28
EA199901014A1 (ru) 2000-06-26
SK168299A3 (en) 2000-09-12
DE69832486T2 (de) 2006-07-27
AU745006C (en) 2006-02-23
TWI224106B (en) 2004-11-21

Similar Documents

Publication Publication Date Title
DZ2515A1 (fr) Dérivés de macrolides substitués en position c-4.
IS5251A (is) 9-oxím erýþrómýsín afleiður
DZ3168A1 (fr) Dérivés de purine.
ATE377018T1 (de) Erythromycinderivate
PT901474E (pt) Derivados de aril-pirimidina.
DK0941998T3 (da) 3,6-ketalmakrolidantibiotika
IS5089A (is) 2 - (Púrín - 9 - ýl) tetrahýdrófúran - 3,4 - díólafleiður
NO993876D0 (no) 3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater
DZ2698A1 (fr) Macrolides nouveaux.
DK1015467T3 (da) 6,9-brobundne erythromycinderivater
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
DK1027362T3 (da) 2-halogen-6-O-substituerede ketolidderivater
NO20014362D0 (no) Erytromycinderivater
DZ3036A1 (fr) Dérivés de monofluoroalkyles.
BR9916188B1 (pt) derivados de cromano.
TR199700354A3 (tr) Karbohidrat türevleri.
ZA983902B (en) Erythromycin derivatives.
PT984975E (pt) Derivados de eritromicina multiciclicos
BR1100453A (pt) derivados de eritromicina
DZ2696A1 (fr) Dérivés glucidiques.
ES1039978Y (es) Dispositivo de articulacion de puertas.
ZA989848B (en) 6,11-bridged erythromycin derivatives
SI1015467T1 (en) 6,9-bridged erythromycin derivatives
SI1027361T1 (en) 6,11-bridged erythromycin derivatives